Obesity and cognitive decline: role of inflammation and vascular changes.
Nguyen JC, Killcross AS, Jenkins TA. · 2014
Read Obesity and cognitive decline: role of inflammation and vascular changes. by Nguyen JC, Killcross AS, Jenkins TA. (2014) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4237034.txt.
Introduction
Jason C. D. Nguyen, A. Simon Killcross, and Trisha A. Jenkins reviewed obesity and the ageing mind in Frontiers in Neuroscience in 2014. Midlife obesity is climbing worldwide, and with it diabetes and heart disease. Evidence also links a heavy midlife body to faster cognitive decline and higher dementia risk later.
The review weighs three candidate routes. Chronic inflammation spilled from fat tissue can reach the brain and stir its immune cells. Vessel changes, including stiff arteries and a leakier blood-brain barrier, starve and injure brain tissue. Metabolic faults such as insulin resistance compound both. Animal and human evidence is laid out for each route, and the authors argue the three interact rather than compete, so prevention may need to address them together.
Catalog record
| CREATOR | Nguyen JC, Killcross AS, Jenkins TA. |
|---|---|
| YEAR | 2014 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 60 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Obesity and cognitive decline: role of inflammation and vascular changes By Jason C. D. Nguyen, A. Simon Killcross, Trisha A. Jenkins Published in: Frontiers in Neuroscience DOI: 10.3389/fnins.2014.00375 ABSTRACT The incidence of obesity in middle age is increasing markedly, and in parallel the prevalence of metabolic disorders including cardiovascular disease and type II diabetes is also rising. Numerous studies have demonstrated that both obesity and metabolic disorders are associated with poorer cognitive performance, cognitive decline, and dementia. In this review we discuss the effects of obesity on cognitive performance, including both clinical and preclinical observations, and discuss some of the potential mechanisms involved, namely inflammation and vascular and metabolic alterations. The incidence of obesity, classified by a body mass index (BMI, body mass divided by the square of one's height) >30 kg/m2, is rising steadily throughout the world's population. Attributed to unhealthy diets (that is over-consumption of food and beverages with a high content of fats, sugars, and salt) and physical inactivity, figures from the Organization for Economic Co-operation and Development 2014 Obesity report (OECD, 2014) suggest that worldwide 18% of the adult population are obese, with more than one in three adults in Mexico, New Zealand and the United States, and more than one in four in Australia, Canada, Chile, and Hungary included in this category. Obesity can have damaging effects on many organ systems. Many of the comorbid conditions are related to metabolic syndrome, characterized by a large waist measurement, high triglyceride levels, glucose intolerance, and hypertension and thus risk factors for the development of non-insulin-dependent (type II) diabetes mellitus, systemic hypertension, coronary artery diseases, and heart failure. Moreover, the incidence of respiratory diseases such as obstructive sleep apnoea, gastrointestinal, and musculoskeletal disorders, thromboembolism, stroke and cancer are increased with obesity (Grundy, 2004; Haslam and James, 2005). In addition, associations between obesity and impaired cognitive function, as well as risk of dementias such as Alzheimer's disease, have more recently been recognized. When we consider the growing population of overweight and obese people worldwide, along with an increasingly aging population, understanding the pathophysiology of obesity on the central nervous system and in particular those subregions important in learning, memory and executive functioning is essential. In this review we will focus on clinical evidence that obesity is associated with cognitive dysfunction and an increased risk of dementia, and complement this with preclinical data from animal models of excess weight gain and cognitive impairment. We will then discuss brain pathological changes that have been observed in these populations, focusing largely on brain regions important in learning and cognition, namely the hippocampus and frontal cortex, before ending with an assessment of the current understanding of dietary-induced systemic and central inflammation within these regions. OBESITY AND COGNITIVE DYSFUNCTION Mild cognitive impairment A growing body of research indicates that obesity in mid-life is a predictor of mild cognitive impairment at old age. Cognitive aging is a normal process where in older adulthood there is a structural and functional change that results in a deterioration of cognitive ability (Glisky, 2007). However, even when controlling for cognitive aging, studies show a negative correlation between BMI and global cognitive performance (Elias et al., 2005; Jeong et al., 2005; Hassing et al., 2010). A cross-sectional longitudinal study of over 2000 middle aged workers supported the linear association between BMI and cognitive function determined by the word-list learning test, which evaluates verbal learning and memory, and Digit-symbol Substitution test (DSST), which assesses attention, response speed, and visuomotor coordination. Obese people recalled fewer words from the list in the word-list learning test and took longer to complete DSST relative to normal weight individuals (Cournot et al., 2006). In another study combining ages from 20 to 82, overweight and obese people exhibited poorer executive function test performance than normal weight adults with no evidence of a BMI x age interaction (Gunstad et al., 2007). Across studies, the different cognitive domains analyzed make it difficult to draw absolute comparisons, but impairment of specific cognitive domains such as executive function and short-term memory have been consistently identified in obese individuals when compared to normal weight counterparts (Cournot et al., 2006; Mond et al., 2007; Lokken et al., 2009; Sabia et al., 2009). Dementia and Alzheimer's disease Obesity is associated with not only an increased risk of development of mild cognitive impairment, but additionally, late-life dementia and Alzheimer's disease (Solfrizzi et al., 2004; Whitmer et al., 2005; Gustafson et al., 2012; Besser et al., 2014). The relative risk of the development of dementia and Alzheimer's disease for obese (BMI ≥ 30 kg/m2) and overweight (BMI = 25–29.9 kg/m2) individuals in midlife compared to normal weight individuals was 2.04 and 1.64, respectively (Anstey et al., 2011). Epidemiological studies have shown that obesity in middle age increases the risk of developing dementia and Alzheimer's disease, irrespective of associated medical conditions such as diabetes or vascular disease (Solfrizzi et al., 2004; Whitmer et al., 2005; Panza et al., 2010; Gustafson et al., 2012; Besser et al., 2014). For example Whitmer and colleagues reported that being overweight at age 40–45 increased ones risk of developing dementia by 35%, while being obese increased this risk to 74% when compared to normal weight individuals (Whitmer et al., 2005). The link of elderly obesity with dementia and Alzheimer's disease is complicated. Several studies have found an age dependent relationship with Alzheimer's disease and late-life obesity (Elias et al., 2003; Gustafson et al., 2003, 2009), while others have shown no or even negative correlations (Buchman et al., 2005; Stewart et al., 2005; Luchsinger et al., 2007; Fitzpatrick et al., 2009). A possible explanation of the confounding results is that weight loss is strongly associated with Alzheimer's disease and occurs before any presentation of cognitive impairment (Buchman et al., 2005; Stewart et al., 2005). Animal models of weight gain Animal models, which allow for more accurate control of diet and other confounding factors than studies in humans, have also found that there is a detrimental effect of diet-induced obesity on cognition. Indeed, in high fat feeding models of obesity, impairments of working memory (Jurdak et al., 2008), learning (Molteni et al., 2002; Murray et al., 2009), and memory performance (Granholm et al., 2008; Kanoski and Davidson, 2010; Kosari et al., 2012) have been observed. A rodent study showed that consumption of a high fat diet (45%) for 3 months caused obesity, insulin resistance, and poor performance in the operant based delayed matching to position task examining short-term information retention and executive function (McNeilly et al., 2011). Furthermore, acquisition rates in learning have been observed to be impaired in rats fed a high fat diet (25%) for 3 months, as evaluated by radial arm water maze, where fat-fed rats took longer and made more errors trying to locate a hidden platform compared to control (Alzoubi et al., 2013). Interestingly, a further study has shown that rats fed a high fat diet (60%) for 3 months have impaired spatial memory that is independent of weight gain and blood pressure change (Kosari et al., 2012). Associations with neuropsychiatric illness There is widespread prevalence of psychiatric symptomatology in individuals diagnosed with mild cognitive impairment and Alzheimer's disease (Lyketsos et al., 2002; Enache et al., 2011), and extensive